UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 29, 2026
Sale
Calculated transaction value
$579.04K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 28, 2026
Public filing date
Oct 29, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$586.48
Oct 28, 2026
First close after public filing
$598.72
Oct 30, 2026
Return after filing · so far
-6.13%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 986 shares @ $587.27
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000174
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.68M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 28, 2026 | $479.05K |
| United Therapeutics Corp UTHR | Exercise | Oct 28, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 28, 2026 | $1.53M |
| United Therapeutics Corp UTHR | Sale | Oct 28, 2026 | $1.81M |
| United Therapeutics Corp UTHR Current | Sale | Oct 28, 2026 | $579.04K |
| United Therapeutics Corp UTHR | Sale | Oct 28, 2026 | $47.07K |
| United Therapeutics Corp UTHR | Sale | Oct 28, 2026 | $1.11M |
| United Therapeutics Corp UTHR | Exercise | Oct 28, 2026 | $0 |